News
Optimize your portfolio review! I’ll grant you that a portfolio review isn’t exciting, and can be tedious really, but if we skip it, we’re...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
This article was written by Follow I’m a full time value investor and writer who enjoys using classical value ratios to pick my portfolio....
News
This article was written by Follow Buffett-style rational value picks | Top 95th percentile of financial bloggers according to TipRanks.Six years of long-horizon investment...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
Humacyte, Inc. (NASDAQ:HUMA) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Lauren Marek – Investor Relations, LifeSci Advisors Laura...
News
Commentary The Polen Focus Growth Composite Portfolio declined -3.28% and -3.47%, gross and net of fees, in the third quarter. This was roughly in...
News
A few months ago, I wrote a review of the iShares iBonds 2025 Term High Yield and Income ETF (IBHE), a fixed term bond...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
Nuvve Holding Corp. (NASDAQ:NVVE) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Eduardo Royes – Investor Relations Gregory Poilasne...
News
Wynn Resorts, Limited (NASDAQ:WYNN) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Julie Cameron-Doe – CFO Craig Billings –...
News
The funny thing about retirement math is that numbers rarely lie. The more money you save, the better off you’ll be. When it comes...
News
Shares of Charles River Laboratories (NYSE:CRL) have had a difficult year, losing about 21% of their value, and those losses continued on Tuesday as...
